OR WAIT null SECS
September 13, 2021
FDA’s recommended guidance is for a system that ‘does not exist, cannot be built by 2023, and poses unacceptable security and compliance risks,’ says alliance
August 13, 2021
Plan aims to offset costs associated with proposed social and health initiatives
July 27, 2021
In-house center eliminates the need for a contract manufacturer, company says
July 19, 2021
Open-to-the-public workshops begin on July 28
July 14, 2021
Biden’s executive order targets drug pricing, healthcare costs and health insurance practices
July 07, 2021
Exploring RCT, RWE and alternative study designs as a path forward
June 17, 2021
Barcode assessment project demonstrates the ground gained in meeting serialization-readiness requirements for supply chain transparency
June 08, 2021
“Aggregation” and “inference” are specifically allowed, under draft guidance
May 13, 2021
Pair of life-sciences data powerhouses are immersed in dispute over their respective data services for pharma sales and marketing
May 06, 2021
The drive for “vaccine equity” around the world is strengthening efforts to limit patent protections on innovative drugs and vaccines to combat Covid
